532296:BOM
Glenmark Pharmaceuticals Ltd
₹2,250.30
arrow_upward
+0.26%(+5.80) 1D
Oct 15, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532296...
Open
₹2,236.05
High
₹2,289.55
Low
₹2,236.05
Mkt. cap
635.15B
Avg. vol.
18.39K
Volume
10.74K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.34
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,236.05
High
₹2,289.55
Low
₹2,236.05
Mkt. cap
635.15B
Avg. vol.
18.39K
Volume
10.74K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.34
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
BigGo Finance
·
42 minutes ago
US Market Rotation Intensifies: Dow Soars 556 Points as Healthcare and Consumer Stocks Take the Baton from Slumping Chips
Yahoo Finance
·
1 hour ago
Grayscale Says Bitcoin’s Volatility Falls to 43%, Now Within S&P 500 Range
TradingView
·
33 minutes ago
News by CNBC TV18 on TradingView, 2026-10-15 — cnbctv:5bbd62cd7094b:0
Eurasia Business News
·
2 hours ago
Stock Market Today: Dow Rises as Investors Rotate Out of Tech
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd